REQUEST A DEMO
Total
USD $0.00
Search more companies

Sol Innocab Private Limited (India)

Main Activities: Architectural and Structural Metals Manufacturing
Full name: Sol Innocab Private Limited Profile Updated: April 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Sol Innocab Private Limited is a company in India, with a head office in North Goa. The enterprise operates in the Architectural and Structural Metals Manufacturing industry. It was incorporated on December 11, 2015. It currently has a total number of 49 (2025) employees. There was a net sales revenue increase of 166.39% reported in Sol Innocab Private Limited’s latest financial highlights for 2025. Its total assets grew by 580.53% over the same period. Sol Innocab Private Limited’s net profit margin increased by 0.81% in 2025.

Legal Address
B50Near Tcpl
North Goa; Goa; Postal Code: 403115

Contact Details: Purchase the Sol Innocab Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Sol Innocab Private Limited report to view the information.
Registered Capital:
Purchase the Sol Innocab Private Limited report to view the information.
Financial Auditors:
Purchase the Sol Innocab Private Limited report to view the information.
Incorporation Date:
December 11, 2015
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Sol Innocab Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
166.39%
Total Operating Revenue
166.01%
Operating Profit
118.97%
EBITDA
160.74%
Net Profit/Loss for the Period
1903.06%
Total Assets
580.53%
Total Equity
201.27%
Operating Profit Margin
-0.72%
Net Profit Margin
0.81%
Return on Equity (ROE)
22.09%
Debt / Equity
1259.87%
Quick Ratio
0.94%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?